Cite
Hoffmann PR, Hoffmann FW, Premeaux TA, et al. Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models. Front Oncol. 2019;9:720doi: 10.3389/fonc.2019.00720.
Hoffmann, P. R., Hoffmann, F. W., Premeaux, T. A., Fujita, T., Soprana, E., Panigada, M., Chew, G. M., Richard, G., Hindocha, P., Menor, M., Khadka, V. S., Deng, Y., Moise, L., Ndhlovu, L. C., Siccardi, A., Weinberg, A. D., De Groot, A. S., & Bertino, P. (2019). Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models. Frontiers in oncology, 9720. https://doi.org/10.3389/fonc.2019.00720
Hoffmann, Peter R, et al. "Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models." Frontiers in oncology vol. 9 (2019): 720. doi: https://doi.org/10.3389/fonc.2019.00720
Hoffmann PR, Hoffmann FW, Premeaux TA, Fujita T, Soprana E, Panigada M, Chew GM, Richard G, Hindocha P, Menor M, Khadka VS, Deng Y, Moise L, Ndhlovu LC, Siccardi A, Weinberg AD, De Groot AS, Bertino P. Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models. Front Oncol. 2019 Aug 02;9:720. doi: 10.3389/fonc.2019.00720. eCollection 2019. PMID: 31428586; PMCID: PMC6688537.
Copy
Download .nbib